TG Therapeutics Completes Licensing Agreement With LFB Biotechnologies for the Development of Ublituximab Closes $25M Financing and Exchange Transaction With Manhattan Pharmaceuticals NEW YORK, March 2, 2012 (GLOBE NEWSW

First Page		Document Content
Date: 2012-12-11 10:28:45		TG Therapeutics Completes Licensing Agreement With LFB Biotechnologies for the Development of Ublituximab Closes $25M Financing and Exchange Transaction With Manhattan Pharmaceuticals NEW YORK, March 2, 2012 (GLOBE NEWSW Add to Reading List Source URL: www.lfb.fr Download Document from Source Website File Size: 38,96 KB Share Document on Facebook